Kerna Laboratories, a San Francisco, CA-based AI biotech startup, raised an undisclosed amount in funding.
Backers included Gradient, Humba Ventures, Tau Ventures, Pioneer Fund, Focalpoint Partners, and angels including Patrick Hsu (Arc Institute) and Jacob Kimmel (NewLimit).
The company intends to use the funds to expand operations and its development efforts.
Founded nine months ago by biotech industry veterans Amit Deshwar (ex-SVP, Deep Genomics), Melissa J. Moore (ex-CSO, Moderna), Julia Peng (CEO), and Michael Swift (Founding Scientist), Kerna Laboratories is an AI biotechnology company dedicated to empowering the mRNA combining advanced AI and science to overcome mRNA payload design for a new therapies.
FinSMEs
13/01/2025